However, the discovery of regulatory T cells (Treg) and Th17 cells not only changes the classical Th1/Th2 paradigm of Th cell differentiation, but also markedly alters conventional thinking regarding the role of CD4+ T cells in anti-tumor immunity [17-21]. Here, CD4 is linked to neoplasm.